Navigation Links
Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy
Date:12/11/2009

PORTLAND, Ore., Dec. 11 /PRNewswire/ -- More than 10 percent of women of Chinese and Korean heritage may be at risk for developing diabetes during pregnancy, according to a Kaiser Permanente study of 16,000 women in Hawaii that appears in the December issue of the Ethnicity and Disease journal. The study also found that Korean-American and Chinese-American women's gestational diabetes risk is one-third higher than average - and more than double that of Caucasian and African-American women.

(Photo: http://www.newscom.com/cgi-bin/prnh/20091211/SF24461)

Funded by the American Diabetes Association, the study found that Pacific Islanders, Filipinos, Puerto Ricans, and Samoans are also at higher-than-average risk - while Caucasian, Native-American, and African-American women have a lower-than-average risk.

Untreated gestational diabetes mellitus, commonly known as GDM, can lead to serious pregnancy and birthing complications, including early delivery and C-sections. It can also increase the child's risk of developing obesity later in life.

While previous studies have shown that GDM is more prevalent among Asian women and Pacific Islanders, this is the first study to separate those ethnic groups into sub-categories to find out who is at higher risk. Researchers chose Hawaii for the study because it has one of the most ethnically diverse populations in the world.

Researchers divided Asians into five ethnic sub-groups and found some striking differences: Korean and Chinese women have the greatest risk of developing GDM. Filipinos are next, but Japanese and Vietnamese women have the same risk as the rest of the population. Among three groups of Pacific Islanders, Samoans and other Pacific Islanders (including women from Fiji and Tahiti) have a higher-than-average risk, while women classified as Native Hawaiians are at average risk.* Caucasian, Native-American, and African-American women have the lowest risk for developing GDM.

"This study has important implications for diagnosis and treatment of gestational diabetes," said study lead author Kathryn Pedula, MS, a researcher at the Kaiser Permanente Center for Health Research. "All pregnant women and their caregivers need to be educated about gestational diabetes, but it is especially important for women in these ethnic groups at higher risk."

"Many previous studies have lumped all Asians and Pacific Islanders together - we now know that the risk for developing GDM varies greatly depending on your specific ethnic background," said study co-author Teresa Hillier, MD, MS, an endocrinologist and senior investigator at the Kaiser Permanente Center for Health Research. "Future studies should also look at whether women in these higher risk groups also have more complications."

This study involved 16,757 women aged 13-39, who gave birth in the Kaiser Permanente Health Plan in Hawaii between 1995 and 2003. Some women had more than one child during that time, bringing the total number of pregnancies to 22,110. Researchers obtained ethnic classification from the mothers' birth certificates on file with the Hawaii Department of Health.

All women in the Kaiser Permanente system are screened for gestational diabetes between 24-28 weeks of pregnancy. If they have GDM, they are treated as part of routine care. More than 20 percent of women in the study had elevated glucose levels, and 6.7 percent of women met the Carpenter and Coustan threshold for gestational diabetes.

"This study underscores Kaiser Permanente's commitment to identify differences in risk and clinical outcomes for different ethnic and racial groups," said Winston F. Wong, MD, MS, medical director of Kaiser Permanente's Community Benefit Disparities Improvement and Quality Initiatives. "While we cannot eliminate the increased risk of prenatal diabetes among our Korean and Chinese patients, we use this kind of research to alert and empower our health care professionals and physicians to reduce disparities and achieve the best possible outcomes for our patients and their children."

Study authors include Kathryn L. Pedula, MS, and Teresa A. Hillier, MD, MS, from the Kaiser Permanente Center for Health Research in Portland, Ore.; Mark M. Schmidt, BA, Kaiser Permanente Center for Health Research, Honolulu; Judith A. Mullen, APRN, BC, CDE, Kaiser Permanente, Honolulu, Hawaii; Marie-Aline Charles, MD, MPH, INSERM, Paris, France; and David J. Pettitt, MD, Sansum Diabetes Research Institute, Santa Barbara, Calif.

About the Kaiser Permanente Center for Health Research (http://www.kpchr.org)

Kaiser Permanente's Center for Health Research, founded in 1964, is a nonprofit research institution dedicated to advancing knowledge to improve health. It has research sites in Portland, Ore., Honolulu and Atlanta.

About Kaiser Permanente

Kaiser Permanente is committed to helping shape the future of health care. We are recognized as one of America's leading health care providers and not-for-profit health plans. Founded in 1945, our mission is to provide high-quality, affordable health care services to improve the health of our members and the communities we serve. We currently serve 8.6 million members in nine states and the District of Columbia. Care for members and patients is focused on their total health and guided by their personal physicians, specialists and team of caregivers. Our expert and caring medical teams are empowered and supported by industry-leading technology advances and tools for health promotion, disease prevention, state-of-the art care delivery and world-class chronic disease management. Kaiser Permanente is dedicated to care innovations, clinical research, health education and the support of community health. For more information, go to: www.kp.org/newscenter.

http://www.kaiserpermanente.org

SOURCE Kaiser Permanente


'/>"/>
SOURCE Kaiser Permanente
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Progesterone Therapy and Preterm Birth: More Evidence Helps Identify Women Who Can Benefit
3. QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome
4. European Experts Recommend Pregnant and Nursing Women Take More DHA - Every Day
5. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
6. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
7. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
8. Cell Therapeutics, Inc. (CTI) Supports Panel Discussion on Women and Lung Cancer on Capitol Hill
9. Risedronate Reduced Risk of Fracture Among Osteoporotic Postmenopausal Women with History of Hip Fracture
10. New Study Shows Once-Monthly Boniva(R) is as Clinically Effective as Once-Weekly Fosamax(R) at Increasing Bone Mineral Density in Postmenopausal Women With Osteoporosis
11. Bay Area Women Sought for Egg Freezing Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... , April 28, 2016 Oramed ... a clinical-stage pharmaceutical company focused on the development of oral ... in the upcoming PIONEERS 2016 conference, presented by Joseph ... 2016 in New York . Nadav ... at the conference. Presentation Details:   ...
(Date:4/28/2016)... Florida , April 28, 2016 ... the development of innovative peptide and gene-based immunotherapeutics and vaccines ... it will be presenting at the 3rd Annual Growth ... - 5 th , 2016 at Caesars Palace in Las Vegas, ... 8.00 am on Wednesday, May 4 th by Dr. ...
(Date:4/27/2016)... , Schweiz, April 27, 2016 ... Sachs CEO Forums in Zürich gab Strekin ... führenden Wirkstoffkandidaten STR001 zur Erhaltung des Resthörvermögens ... wurde, bekannt. Für die umfassende Phase-II-Doppelblindstudie mit ... Frankreich angeworben. STR001 wird während der Operation ...
Breaking Medicine Technology:
(Date:4/28/2016)... Viejo, CA (PRWEB) , ... April 28, 2016 , ... ... use within Final Cut Pro X . With ProText Layouts, video editors ... tweak animations to match the length and scale of texts. Creating text-based videos ...
(Date:4/28/2016)... ... , ... Head Over Heels Athletic Arts’ gymnast, Brooklyn Varize, has qualified to ... at the University of Montana on April 28-May 1. Varize will compete on Saturday ... order to qualify, Varize needed to place top seven all-around in her respective age ...
(Date:4/28/2016)... ... April 28, 2016 , ... The ... successful events, attracting medical professionals from around the globe who attended a week’s ... Opening Ceremonies Sunday, April 17 included the introduction of the 2016 ARRS Distinguished ...
(Date:4/28/2016)... ... April 28, 2016 , ... Greener Hydroponics is now offering a ... frequently used by professional organic farmers and nurseries according to Sales Manager Joe Steele ... fabric pots. Our goal is to offer wholesale level pricing and ultra-fast shipping for ...
(Date:4/28/2016)... ... April 28, 2016 , ... Horizon ... collaborating with doctors and hospitals to make transformative changes in how health care ... therapy minds this week in discussing breakthroughs in cellular medicine to treat disease. ...
Breaking Medicine News(10 mins):